Standard management of sickle cell disease complications

Area of Science:

• Hematology
• Public Health
• Genetics

Background:

• Sickle cell disease (SCD) is a significant global health issue, particularly in sub-Saharan Africa, Europe, and the US.
• While pediatric survival rates have risen in developed countries, adult survival rates have not kept pace.
• Advances in hydroxyurea treatment and stroke prevention have driven improvements in pediatric care.

Purpose of the Study:

• To review current management strategies for major sickle cell disease complications.
• To highlight the role of hydroxyurea and transfusion therapy in managing SCD.
• To provide an overview of recent advancements in SCD care.

Main Methods:

• Literature review of current management protocols for SCD.
• Analysis of hydroxyurea efficacy in pediatric and adult populations.
• Examination of transfusion therapy in sickle cell disease management.

Main Results:

• Hydroxyurea and stroke prevention strategies have significantly improved pediatric survival rates in developed countries.
• Adult survival rates in sickle cell disease patients lag behind pediatric rates.
• Current therapeutic approaches focus on managing pain, stroke, and acute chest syndrome.

Conclusions:

• Continued research and implementation of advanced treatments are crucial for improving adult survival in sickle cell disease.
• Hydroxyurea and transfusion therapy remain cornerstone treatments for managing SCD complications.
• Addressing disparities in care is essential for global sickle cell disease management.